Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PhageLab is a biotechnology company focused on developing bacteriophage-based alternatives to antibiotics for the livestock industry. The company leverages a proprietary AI-driven platform to analyze bacterial genomes and design customized phage cocktails that specifically target and eliminate pathogenic bacteria such as Salmonella and E. coli. By integrating bioinformatics and high-throughput screening, PhageLab provides rapid, scalable solutions to combat antimicrobial resistance in animal production. Their products are currently deployed in the poultry and swine sectors to enhance food safety and animal welfare. The company is headquartered in Chile and is expanding its commercial footprint across Latin America and global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PhageLab.